Seer Inc (NAS:SEER)
$ 2.47 -0.03 (-1.2%) Market Cap: 145.65 Mil Enterprise Value: -75.45 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 56/100

Seer Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2022 / 04:15PM GMT
Release Date Price: $19.02 (+1.98%)
Ruizhi Qin
JPMorgan Chase & Co, Research Division - Analyst

All right. Good morning, everyone. This is Julia Qin from the life science team at JPMorgan. It's my great pleasure to introduce you to our next presentation by Seer. As a reminder, if you have a question, you can submit it through the website. And with that, let me turn it over to Omid.

Omid C. Farokhzad
Seer, Inc. - Founder, CEO & Chair of the Board of Directors

Good morning, everyone, and thanks so much, Julia, Tycho and the JPMorgan team for the opportunity to present today. I'm Omid Farokhzad, CEO and Founder of Seer, a company which I founded back in 2017 and went public in December of 2020. I'm going to walk you through some of the foundational aspects of our company, the progress we've made in our first year as a public company and share with you why we believe Seer is leading the proteomics revolution. My presentation today will be followed by a Q&A with myself and David Horn, our Chief Financial Officer.

Now please note our safe harbor disclosure, which indicates that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot